Free Trial

Aberdeen Group plc Sells 7,913 Shares of Synopsys, Inc. $SNPS

Synopsys logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Aberdeen Group plc trimmed its Synopsys stake by 5.3%, selling 7,913 shares and finishing the quarter with 140,295 shares worth roughly $65.9 million.
  • Synopsys beat quarterly expectations with EPS of $3.77 (vs. $3.56 est.) and revenue of $2.41 billion (up 65.6% YoY), and provided FY2026 EPS guidance of 14.380–14.460 and Q2 guidance of 3.110–3.170.
  • Analyst sentiment is mixed: the consensus rating is Hold with a $531 average target, while individual price targets span about $430 to $650, and institutional investors own roughly 85% of the stock.
  • Five stocks to consider instead of Synopsys.

Aberdeen Group plc decreased its position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 5.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 140,295 shares of the semiconductor company's stock after selling 7,913 shares during the period. Aberdeen Group plc owned 0.07% of Synopsys worth $65,899,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Alpine Bank Wealth Management raised its holdings in shares of Synopsys by 89.3% in the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company's stock worth $26,000 after buying an additional 25 shares in the last quarter. TFC Financial Management Inc. raised its position in Synopsys by 1,250.0% in the 3rd quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company's stock worth $27,000 after purchasing an additional 50 shares during the last quarter. Millstone Evans Group LLC bought a new stake in shares of Synopsys during the third quarter worth $27,000. SOA Wealth Advisors LLC. bought a new position in Synopsys in the third quarter valued at approximately $28,000. Finally, McIlrath & Eck LLC acquired a new stake in Synopsys during the 3rd quarter worth $29,000. 85.47% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on SNPS shares. Piper Sandler dropped their price target on Synopsys from $520.00 to $430.00 and set a "neutral" rating on the stock in a research report on Thursday, February 26th. The Goldman Sachs Group set a $600.00 price objective on Synopsys and gave the company a "buy" rating in a research note on Wednesday, February 25th. JPMorgan Chase & Co. increased their target price on Synopsys from $600.00 to $650.00 and gave the stock an "overweight" rating in a research note on Thursday, December 11th. Needham & Company LLC reaffirmed a "buy" rating on shares of Synopsys in a report on Thursday, February 26th. Finally, Bank of America upgraded Synopsys from an "underperform" rating to a "neutral" rating and cut their price target for the company from $525.00 to $500.00 in a research note on Monday, December 8th. Eight analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $531.00.

Get Our Latest Stock Analysis on SNPS

Insider Transactions at Synopsys

In other Synopsys news, insider Janet Lee sold 250 shares of the stock in a transaction on Monday, January 12th. The stock was sold at an average price of $530.00, for a total transaction of $132,500.00. Following the sale, the insider owned 11,959 shares in the company, valued at $6,338,270. This represents a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.56% of the stock is owned by insiders.

Synopsys Price Performance

Shares of NASDAQ:SNPS opened at $395.95 on Friday. The business's 50 day moving average is $430.80 and its 200 day moving average is $449.68. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $651.73. The stock has a market cap of $75.85 billion, a price-to-earnings ratio of 61.48, a PEG ratio of 3.23 and a beta of 1.15. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33.

Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings data on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share for the quarter, beating the consensus estimate of $3.56 by $0.21. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.The business had revenue of $2.41 billion for the quarter, compared to analysts' expectations of $2.39 billion. During the same period last year, the business earned $3.03 EPS. The business's revenue was up 65.6% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. On average, sell-side analysts forecast that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

About Synopsys

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Recommended Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines